blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4069228

EP4069228 - PROCESSES FOR PREPARING 2-(4-CHLOROPHENYL)-N-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-5-YL)METHYL)-2,2-DIFLUOROACETAMIDE [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  09.09.2022
Database last updated on 13.11.2024
FormerThe international publication has been made
Status updated on  11.06.2021
Most recent event   Tooltip24.10.2024New entry: Application deemed to be withdrawn: despatch of communication + time limit 
Applicant(s)For all designated states
Celgene Corporation
Route 206 & Province Line Road
Princeton, NJ 08543 / US
[2024/14]
Former [2022/41]For all designated states
Celgene Corporation
86 Morris Avenue
Summit, NJ 07901 / US
Inventor(s)01 / BEAUCHAMPS, Marie, G.
556 Morris Avenue
Summit, NJ 07901 / US
02 / FEIGELSON, Gregg
556 Morris Avenue
Summit, NJ 07901 / US
03 / HAN, Jianxin
556 Morris Avenue
Summit, NJ 07901 / US
04 / HANSEN, Joshua
10300 Campus Point Drive, Suite 100
San Diego, CA 92121 / US
05 / KOTHARE, Mohit, A.
556 Morris Avenue
Summit, NJ 07901 / US
06 / WILLIAMS, Michael, James
556 Morris Avenue
Summit, NJ 07901 / US
07 / ZACUTO, Michael, J.
556 Morris Avenue
Summit, NJ 07901 / US
08 / ZHAN, Weihong
556 Morris Avenue
Summit, NJ 07901 / US
 [2022/41]
Representative(s)Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[2022/41]
Application number, filing date20895373.704.12.2020
[2022/41]
WO2020US63195
Priority number, dateUS201962945013P06.12.2019         Original published format: US 201962945013 P
[2022/41]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021113566
Date:10.06.2021
Language:EN
[2021/23]
Type: A1 Application with search report 
No.:EP4069228
Date:12.10.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 10.06.2021 takes the place of the publication of the European patent application.
[2022/41]
Search report(s)International search report - published on:US10.06.2021
(Supplementary) European search report - dispatched on:EP18.03.2024
ClassificationIPC:C07D401/04, A61K31/4523, A61K31/454
[2024/01]
CPC:
C07D401/04 (EP,IL,KR,US); C07C253/04 (KR); C07C253/16 (KR);
C07C255/55 (KR); C07B2200/13 (IL,KR,US)
Former IPC [2022/41]A61K31/4523, A61K31/454, C07D401/04
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/41]
TitleGerman:VERFAHREN ZUR HERSTELLUNG VON 2-(4-CHLORPHENYL)-N-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-5-YL)METHYL)-2,2-DIFLUORACETAMID[2022/41]
English:PROCESSES FOR PREPARING 2-(4-CHLOROPHENYL)-N-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-5-YL)METHYL)-2,2-DIFLUOROACETAMIDE[2022/41]
French:PROCÉDÉS POUR LA PRÉPARATION DU 2-(4-CHLOROPHÉNYL)-N-((2-(2,6-DIOXOPIPÉRIDIN-3-YL)-1-OXOISOINDOLIN-5-YL)MÉTHYL)-2,2-DIFLUOROACÉTAMIDE[2022/41]
Entry into regional phase27.05.2022National basic fee paid 
27.05.2022Search fee paid 
27.05.2022Designation fee(s) paid 
27.05.2022Examination fee paid 
Examination procedure27.05.2022Examination requested  [2022/41]
17.01.2023Amendment by applicant (claims and/or description)
23.10.2024Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
Fees paidRenewal fee
04.07.2022Renewal fee patent year 03
15.11.2023Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]EP1362856  (SANKYO CO [JP]);
 [A]WO2016007848  (CELGENE CORP [US]);
 [A]WO2017120446  (CELGENE CORP [US]);
 [A]WO2019136016  (CELGENE CORP [US]);
 [AP]WO2019241274  (BIOTHERYX INC [US]);
 [AP]WO2020242960  (BIOTHERYX INC [US]);
International search[Y]US5468881  (EBATA TAKASHI [JP], et al) [Y] 27; 28 * Col 1, In 53-58; Col 2, In 10-20; Col 2, In 28-40; Col 3, In 45-55 *;
 [Y]WO9719074  (HOECHST MARION ROUSSEL INC [US]) [Y] 12-18; 20; 21 ; 34-37; 42-46 * pg. 50, scheme A1; pg. 54, In 29 to pg. 55, In 11 *;
 [YA]US6248925  (FORD MICHAEL EDWARD [US], et al) [Y] 7; 10; 11; 38; 41-46 * abstract; Col 2, In 50-59; Col 2. In 63-65; Col 4, In 24-33 * [A] 25; 26;
 [YA]US6753433  (HILDEN LEIF [FI], et al) [Y] 27; 28 * Col 3, In 65-67, Scheme 1 * [A] 25; 26;
 [Y]US2008200648  (GIRAUD MATTHIEU [CH], et al) [Y] 1-18; 20; 21 ; 38 * para [0007]; [0021]; [0050], Table 1 *;
 [Y]US8907132  (REDDY MANNE SATYANARAYANA [IN], et al) [Y] 29-33 * Col 5, In 38-41; Col 6, In 36-53; Col 6, In 56-58; Col 17, In 7-9 *;
 [YA]US2018221361  (CATHERS BRIAN E [US], et al) [Y] 1-18; 20; 21 ; 29-46 * para [0741]; [0747]; [0749]; [0761]-[0762]; pg. 40-41, Scheme * [A] 25; 26;
 [XA]US2019106405  (FERNANDEZ PAUL F [US], et al) [X] 39; 47; 48 * para [0023]-[0024]; [0143]-[0144]; [0443] * [A] 25; 26;
 [Y]  - A. Leggio, E. L. Belsito, G. De Luca, M. L. Di Gioia, V. Leotta, E. Romio, C. Siciliano, A. Liguori, "One-pot synthesis of amides from carboxylic acids activated using thionyl chloride", RSC Advances, (20160101), vol. 6, no. 41, doi:10.1039/C5RA24527C, pages 34468 - 34475, XP055560032 [Y] 40-46 * . abstract; pg. 2, Table 1 *

DOI:   http://dx.doi.org/10.1039/C5RA24527C
 [Y]  - BERNSTEIN et al., "16-hydroxylated steroids . XXIII. 21-Chloro-16a-hydroxycorticoids and Their 16a,17a-acetonides", Journal of Organic Chemistry, (19620000), vol. 27, no. 2, pages 690 - 692, XP055834366 [Y] 29-33 * . pg. 691, Col 1, para 2 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.